about
Expression of Plasmodium falciparum erythrocyte membrane protein 1 in experimentally infected humansSub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regionsDifferent mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance markerThe Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria VaccineDifferential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSAPlacental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malariaTargeted disruption of a ring-infected erythrocyte surface antigen (RESA)-like export protein gene in Plasmodium falciparum confers stable chondroitin 4-sulfate cytoadherence capacityReal-time and label free determination of ligand binding-kinetics to primary cancer tissue specimens; a novel tool for the assessment of biomarker targeting.IgM, Fc mu Rs, and malarial immune evasionEpitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration.Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSAPlasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression.A method for visualizing surface-exposed and internal PfEMP1 adhesion antigens in Plasmodium falciparum infected erythrocytes.Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSAAn upstream open reading frame controls translation of var2csa, a gene implicated in placental malaria.Multiple var2csa-type PfEMP1 genes located at different chromosomal loci occur in many Plasmodium falciparum isolatesSeveral domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies.The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs.Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies.Dual stage synthesis and crucial role of cytoadherence-linked asexual gene 9 in the surface expression of malaria parasite var proteinsThe chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domainsHigh avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria.Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.Identification and characterization of B-cell epitopes in the DBL4ε domain of VAR2CSABacterial superglue enables easy development of efficient virus-like particle based vaccines.VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria.Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytes.Cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate is cooperative and shear enhanced.Positive selection of Plasmodium falciparum parasites with multiple var2csa-type PfEMP1 genes during the course of infection in pregnant women.DNA secondary structures are associated with recombination in major Plasmodium falciparum variable surface antigen gene families.The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding siteLack of gender-specific antibody recognition of products from domains of a var gene implicated in pregnancy-associated Plasmodium falciparum malaria.Limited cross-reactivity among domains of the Plasmodium falciparum clone 3D7 erythrocyte membrane protein 1 family.Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, BeninIdentification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA.A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.Changes in var gene mRNA levels during erythrocytic development in two phenotypically distinct Plasmodium falciparum parasitesHigh levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.Molecular dissection of placental malaria protein VAR2CSA interaction with a chemo-enzymatically synthesized chondroitin sulfate library.
P50
Q24804115-A9E3EE98-05C9-4EB4-824C-42E5D6288A29Q24804747-9620E425-1832-4722-AD68-6A459542352CQ24806780-02D48DC3-B1C5-4C7F-9B67-6D2AFB76FE42Q27300745-EACB22B0-0F6B-448F-8741-709800FD021FQ27349502-3608E844-8B57-4CE1-A84C-A902BB96AA18Q27973758-4714F9D3-4B50-461B-871E-5D480A5D20A6Q27976511-2C2F33C4-A3C9-44EE-A49B-D136DD9819D4Q30042328-D2BA08D5-E73D-4470-A4E3-BE0505735088Q30378832-CC7BDC7F-5BE3-427B-9B57-BA2327804BB5Q30432532-112BC609-E81B-443C-BC0D-F1226BA4B162Q33263953-A3898CB4-A693-4627-9ED2-93F6674E1CF3Q33320197-9202E876-7354-420E-AC11-DB501781085CQ33325481-E80E37A2-AECB-43AC-A137-320AEC5A1551Q33340826-0D9BC47A-F6D0-4356-BB9E-DD74D94AFF7AQ33340867-CB6B6594-1104-45AF-9C3D-FE7623706370Q33396980-9B071EFE-B453-4836-8C14-7BEB52649C72Q33494832-1C6FC146-62C2-4C5C-B1A8-32F1416BAAB7Q33634689-BE8DFE52-E104-420C-BED5-634746B5A597Q33846617-59DF9E3C-C812-48C4-8C6D-5EFD41159643Q34095324-0F38E6E9-D339-4DFC-88AC-8C9A1691A707Q34151684-6AD4CD11-D309-4661-A35F-90DD0DDF835DQ34170375-872695F2-B663-4955-999C-2572A26088EEQ34326742-85AB0C5F-A880-44D5-BB3A-4AFD3767259AQ34364093-60FEA30E-0FAD-438F-A3FE-0E8FC189710CQ34412101-701562B6-5B7E-4F1D-9E27-56D755B5E85DQ34523734-02366EC5-47EA-4759-AAFC-37D9CEB9EAA4Q34706475-1BB703F4-E9C4-4E90-B1BA-5516DE3ECF1AQ34721210-7F4A7E80-6276-42DA-BE93-AA9F2D76B909Q34876859-BFE2C6CD-0B2A-46F6-A74B-4FFBAA79040EQ34988334-3529E245-1F46-4AF5-A95D-2041853D0999Q35047158-71A65081-CBE1-4477-9BF6-A7D180CEFE27Q35088554-F9770F51-F47B-4F5D-8EF3-B0062B14230BQ35106301-7885E19A-3019-43E5-B8DA-2F9A6A28C1DBQ35220304-7DF2EE04-B866-40B8-9532-CC3DD4BB4284Q35546075-AC8134B0-444C-47CA-AD24-A36665CCF16AQ35783076-5EF7CB03-D890-47EC-A513-2D175868AB6DQ35850159-BFE7DCBD-D271-4CD1-8F3B-630CE76EF206Q35865612-40586DB3-9B33-439E-AB37-4BBDF6151C8EQ35867607-79362B1A-AB2E-4527-A5C8-D536C868D3F4Q36048885-BBB6A696-9352-458E-8626-93D01424AA76
P50
description
forsker fra Københavns Universitet
@da
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ali Salanti
@ast
Ali Salanti
@da
Ali Salanti
@de
Ali Salanti
@en
Ali Salanti
@es
Ali Salanti
@fo
Ali Salanti
@fr
Ali Salanti
@is
Ali Salanti
@kl
Ali Salanti
@nb
type
label
Ali Salanti
@ast
Ali Salanti
@da
Ali Salanti
@de
Ali Salanti
@en
Ali Salanti
@es
Ali Salanti
@fo
Ali Salanti
@fr
Ali Salanti
@is
Ali Salanti
@kl
Ali Salanti
@nb
prefLabel
Ali Salanti
@ast
Ali Salanti
@da
Ali Salanti
@de
Ali Salanti
@en
Ali Salanti
@es
Ali Salanti
@fo
Ali Salanti
@fr
Ali Salanti
@is
Ali Salanti
@kl
Ali Salanti
@nb
P69
P106
P1153
6602328173
P1960
7oElXKcAAAAJ
P21
P31
P496
0000-0003-2207-5575
P569
1974-01-01T00:00:00Z